Page last updated: 2024-10-22

acetazolamide and Tremor

acetazolamide has been researched along with Tremor in 4 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.

Research Excerpts

ExcerptRelevanceReference
"We studied the effect of the carbonic anhydrase inhibitor acetazolamide on 24 patients with essential tremor by patient self-evaluation of functional disability, rating of motor task function, and clinical rating of tremor severity."9.07The effect of acetazolamide on essential tremor: an open-label trial. ( Busenbark, K; Hubble, J; Koller, W; Pahwa, R, 1992)
"We studied the effect of the carbonic anhydrase inhibitor acetazolamide on 24 patients with essential tremor by patient self-evaluation of functional disability, rating of motor task function, and clinical rating of tremor severity."5.07The effect of acetazolamide on essential tremor: an open-label trial. ( Busenbark, K; Hubble, J; Koller, W; Pahwa, R, 1992)
" The paroxysms took the form ot brief unilateral dystonic posturings of the right body suggestive of paroxysmal dystonia (PD); they completely receded with acetazolamide."3.69Paroxysmal dystonia and paroxysmal tremor in a young patient with multiple sclerosis. ( Angelini, L; Nardocci, N; Rumi, V; Savoldelli, M; Zorzi, G, 1995)
"Limb shaking in Moyamoya disease may result from a transient hypoperfusion of the contralateral frontoparietal cortex rather than basal ganglia."1.32Hyperventilation-induced limb shaking TIA in Moyamoya disease. ( Chung, CS; Han, DH; Kim, HY; Lee, J; Lee, KH, 2003)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, HY1
Chung, CS1
Lee, J1
Han, DH1
Lee, KH1
Lancman, ME1
Asconapé, JJ1
Walker, F1
Nardocci, N1
Zorzi, G1
Savoldelli, M1
Rumi, V1
Angelini, L1
Busenbark, K1
Pahwa, R1
Hubble, J1
Koller, W1

Trials

1 trial available for acetazolamide and Tremor

ArticleYear
The effect of acetazolamide on essential tremor: an open-label trial.
    Neurology, 1992, Volume: 42, Issue:7

    Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Tremor

1992

Other Studies

3 other studies available for acetazolamide and Tremor

ArticleYear
Hyperventilation-induced limb shaking TIA in Moyamoya disease.
    Neurology, 2003, Jan-14, Volume: 60, Issue:1

    Topics: Acetazolamide; Adult; Angiography; Carbonic Anhydrase Inhibitors; Carotid Stenosis; Collateral Circu

2003
Acetazolamide appears effective in the management of valproate-induced tremor.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:3

    Topics: Acetazolamide; Drug Therapy, Combination; Epilepsy, Post-Traumatic; Humans; Male; Middle Aged; Motor

1994
Paroxysmal dystonia and paroxysmal tremor in a young patient with multiple sclerosis.
    Italian journal of neurological sciences, 1995, Volume: 16, Issue:5

    Topics: Acetazolamide; Adolescent; Dystonia; Female; Humans; Magnetic Resonance Imaging; Multiple Sclerosis;

1995